The annual DEA National Threat Assessment, which covers 2019 and the first half of 2020, is the best source of unclassified data on drug smuggling, illicit substance trafficking, and counterfeit medications as it affects Americans. Watch our News of the Week video at right, or read the high points on our Twitter thread. Below you’ll…[...]
A pair of men from Ukraine admitted in federal court that they conspired to smuggle and distribute counterfeit cancer and hepatitis C drugs into the United States. Maksym Nienadov, the owner of the Ukrainian-based company Healthy Nation, and his co-conspirator and employee – Volodymyr Nikolaienko – pleaded guilty in federal court in Houston, Texas to conspiracy, trafficking in counterfeit drugs and smuggling goods into the country.[...]
Each year, the U.S. Drug Enforcement Administration pools the knowledge of law enforcement agencies around the country to produce its National Drug Threat Assessment. This year, fentanyl, counterfeit prescription pills, and the pill presses are all listed as things that will continue to endanger American lives…[...]
According to a notice on the L.A. City Attorney’s website, the Dominguez family allegedly ran a counterfeit drug operation that sold approximately 13,848 counterfeit and misbranded pharmaceuticals, including counterfeit and misbranded versions of anti-seizure and blood pressure medications, injectable birth control and steroids, among others.[...]
The U.S. Food and Drug Administration (FDA) has just announced a successful joint operation with the Government of India targeting counterfeit prescription drugs, counterfeit over-the-counter medications, fake medical devices, and misbranded dietary supplements containing harmful ingredients.[...]
According to a report from Europol’s Intellectual Property Crime Threat Assessment 2019, “Counterfeit pharmaceuticals pose a growing threat to the EU, affecting a large number of Member States. A wide and increasingly diverse range of medicines is targeted by counterfeiters.”
The Europol ICP Threat Assessment reports that there has been an increase in seizures of counterfeit drugs used in the treatment of serious illnesses, as well as a growing number of counterfeit drug incidents affecting the legal drug supply chain.
The U.S. Department of Justice announced that Stephan Caamano, who manufactured and sold at least 4.3 million counterfeit Xanax pills, will spend the next 13 years in federal prison after pleading guilty to his crimes…[...]